• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRPM2反义RNA通过miR-6764-5p上调附近基因TRPM2,促进卵巢癌细胞增殖并抑制细胞凋亡。

TRPM2-AS promotes ovarian cancer cell proliferation and inhibits cell apoptosis by upregulating the nearby gene TRPM2 via miR-6764-5p.

作者信息

Zhu Wei, Mao Shiqin, Jiang Juan

机构信息

Department of Gynecology, People's Hospital of Jingjiang, No. 28, Zhongzhou Road, Jingjiang City, Taizhou City, 214500, Jiangsu Province, China.

出版信息

Cell Div. 2024 Aug 27;19(1):26. doi: 10.1186/s13008-024-00130-0.

DOI:10.1186/s13008-024-00130-0
PMID:39192251
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11351637/
Abstract

Ovarian cancer (OC) becomes a fatal gynecologic malignant cancer in females worldwide. Target therapy is a promising therapeutical choice for patients with OC, and identifying biomarkers and exploring molecular mechanisms are necessary. In this study, the functions and mechanism of long noncoding RNA transient receptor potential cation channel subfamily M member 2 antisense RNA (TRPM2-AS) in OC were explored. TRPM2-AS expression in OC cells was analyzed utilizing reverse transcription quantitative polymerase chain reaction (RT-qPCR). Cell counting kit-8 (CCK-8) and colony forming assays were carried out to explore the influence of TRPM2-AS on OC cell viability and proliferation. Cell apoptosis was detected using TdT-mediated dUTP Nick-End labeling (TUNEL) and flow cytometry analysis. Protein expression of apoptotic markers was subjected to western blotting. RNA pulldown or luciferase reporter assays were applied to explore the interaction between TRPM2-AS and miR-6764-5p or the binding of miR-6764-5p and TRPM2. The results showed that TRPM2-AS is highly expressed in OC cells and was mainly localized in cytoplasm. TRPM2-AS depletion suppressed OC cell viability and proliferation while increasing cell apoptotic rate. TRPM2 displayed a high level in OC cells and was positively regulated by TRPM2-AS. TRPM2-AS interacted with miR-6764-5p and thereby upregulated TRPM2 expression. In addition, TRPM2 overexpression reversed the repressive impact of TRPM2-AS depletion on malignant OC cellular process. In conclusion, TRPM2-AS promotes OC cell viability and proliferation while enhancing cell apoptosis through interaction with miR-6764-5p to regulate TRPM2 level.

摘要

卵巢癌(OC)是全球女性中一种致命的妇科恶性肿瘤。靶向治疗是OC患者一种有前景的治疗选择,识别生物标志物并探索分子机制很有必要。在本研究中,探讨了长链非编码RNA瞬时受体电位阳离子通道亚家族M成员2反义RNA(TRPM2-AS)在OC中的功能和机制。利用逆转录定量聚合酶链反应(RT-qPCR)分析OC细胞中TRPM2-AS的表达。进行细胞计数试剂盒-8(CCK-8)和集落形成试验,以探讨TRPM2-AS对OC细胞活力和增殖的影响。使用TdT介导的dUTP缺口末端标记(TUNEL)和流式细胞术分析检测细胞凋亡。对凋亡标志物的蛋白表达进行蛋白质印迹分析。应用RNA下拉或荧光素酶报告基因试验来探索TRPM2-AS与miR-6764-5p之间的相互作用或miR-6764-5p与TRPM2的结合。结果表明,TRPM2-AS在OC细胞中高表达,且主要定位于细胞质中。TRPM2-AS的缺失抑制了OC细胞的活力和增殖,同时增加了细胞凋亡率。TRPM2在OC细胞中呈现高水平,且受TRPM2-AS的正向调控。TRPM2-AS与miR-6764-5p相互作用,从而上调TRPM2的表达。此外,TRPM2的过表达逆转了TRPM2-AS缺失对恶性OC细胞进程的抑制作用。总之,TRPM2-AS通过与miR-6764-5p相互作用调节TRPM2水平,从而促进OC细胞的活力和增殖,同时增强细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/8ec336f75cf1/13008_2024_130_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/69c4d22baaf3/13008_2024_130_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/2571eafad3be/13008_2024_130_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/cf1cc8707089/13008_2024_130_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/fbc94f81ba6f/13008_2024_130_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/5c017f619764/13008_2024_130_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/8ec336f75cf1/13008_2024_130_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/69c4d22baaf3/13008_2024_130_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/2571eafad3be/13008_2024_130_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/cf1cc8707089/13008_2024_130_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/fbc94f81ba6f/13008_2024_130_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/5c017f619764/13008_2024_130_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5953/11351637/8ec336f75cf1/13008_2024_130_Fig6_HTML.jpg

相似文献

1
TRPM2-AS promotes ovarian cancer cell proliferation and inhibits cell apoptosis by upregulating the nearby gene TRPM2 via miR-6764-5p.TRPM2反义RNA通过miR-6764-5p上调附近基因TRPM2,促进卵巢癌细胞增殖并抑制细胞凋亡。
Cell Div. 2024 Aug 27;19(1):26. doi: 10.1186/s13008-024-00130-0.
2
Circ_0000471 suppresses the progression of ovarian cancer through mediating mir-135b-5p/dusp5 axis.环状RNA_0000471通过介导微小RNA-135b-5p/双特异性磷酸酶5轴抑制卵巢癌进展。
Am J Reprod Immunol. 2023 Apr;89(4):e13651. doi: 10.1111/aji.13651. Epub 2023 Feb 13.
3
GAS5 Suppresses Cell Proliferation, Migration, and Invasion via the miR-455-5p/CDKN1B Axis in Cutaneous Squamous Cell Carcinoma.GAS5 通过 miR-455-5p/CDKN1B 轴抑制皮肤鳞状细胞癌中的细胞增殖、迁移和侵袭。
Crit Rev Eukaryot Gene Expr. 2022;32(5):63-76. doi: 10.1615/CritRevEukaryotGeneExpr.2022042215.
4
F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.F-Box 和亮氨酸丰富重复蛋白 20(FBXL20)受 microRNA(miR)-195-5p 负调控,加速卵巢癌的恶性进展。
Mol Biotechnol. 2021 Dec;63(12):1235-1243. doi: 10.1007/s12033-021-00375-y. Epub 2021 Aug 2.
5
LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.LINC-PINT 通过靶向 miR-374a-5p 抑制卵巢癌细胞的增殖、迁移和侵袭。
Cell Biochem Funct. 2020 Dec;38(8):1089-1099. doi: 10.1002/cbf.3565. Epub 2020 Jul 7.
6
LncRNA TRPM2-AS promotes endometrial carcinoma progression and angiogenesis via targeting miR-497-5p/SPP1 axis.长链非编码 RNA TRPM2-AS 通过靶向 miR-497-5p/SPP1 轴促进子宫内膜癌的进展和血管生成。
Cell Mol Biol Lett. 2024 Jul 2;29(1):93. doi: 10.1186/s11658-024-00612-7.
7
Circ_0061140 Contributes to the Malignant Progression in Ovarian Cancer Cells by Mediating the RAB1A Level Through Sponging miR-361-5p.环状 RNA 0061140 通过海绵吸附 miR-361-5p 介导 RAB1A 水平促进卵巢癌细胞的恶性进展。
Biochem Genet. 2022 Dec;60(6):1946-1962. doi: 10.1007/s10528-022-10200-z. Epub 2022 Feb 18.
8
Mechanism underlying the regulation of lncRNA ACTA2-AS1 on CXCL2 by absorbing miRNA-532-5p as ceRNA in the development of ovarian cancer.lncRNA ACTA2-AS1在卵巢癌发生发展过程中作为竞争性内源RNA(ceRNA)通过吸附miRNA-532-5p调控CXCL2的潜在机制。
Int J Clin Exp Pathol. 2021 May 15;14(5):596-607. eCollection 2021.
9
Long non-coding RNA TRPM2 antisense RNA as a potential therapeutic target promotes tumorigenesis and metastasis in esophageal cancer.长链非编码 RNA TRPM2 反义 RNA 作为一种潜在的治疗靶点促进食管癌的发生和转移。
Bioengineered. 2022 Feb;13(2):4397-4410. doi: 10.1080/21655979.2022.2033412.
10
LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.长链非编码 RNA MNX1-AS1 通过靶向 miR-744-5p/SOX12 轴促进卵巢癌细胞进程。
J Ovarian Res. 2021 Nov 17;14(1):161. doi: 10.1186/s13048-021-00910-0.

引用本文的文献

1
Inter-Organelle Crosstalk in Oxidative Distress: A Unified TRPM2-NOX2 Mediated Vicious Cycle Involving Ca, Zn, and ROS Amplification.氧化应激中的细胞器间串扰:由TRPM2-NOX2介导的涉及钙、锌和活性氧放大的统一恶性循环
Antioxidants (Basel). 2025 Jun 24;14(7):776. doi: 10.3390/antiox14070776.
2
Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers.长链非编码RNA TRPM2-AS在癌症中的临床意义及致病机制
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251315625. doi: 10.1177/15330338251315625.

本文引用的文献

1
A macrophage related signature for predicting prognosis and drug sensitivity in ovarian cancer based on integrative machine learning.基于集成机器学习的巨噬细胞相关特征预测卵巢癌预后和药物敏感性。
BMC Med Genomics. 2023 Oct 2;16(1):230. doi: 10.1186/s12920-023-01671-z.
2
Identification of TRPM2 as a prognostic factor correlated with immune infiltration in ovarian cancer.鉴定 TRPM2 作为与卵巢癌免疫浸润相关的预后因素。
J Ovarian Res. 2023 Aug 22;16(1):169. doi: 10.1186/s13048-023-01225-y.
3
Identification of TRPM2 as a Potential Therapeutic Target Associated with Immune Infiltration: A Comprehensive Pan-Cancer Analysis and Experimental Verification in Ovarian Cancer.
鉴定TRPM2作为与免疫浸润相关的潜在治疗靶点:一项全面的泛癌分析及卵巢癌实验验证
Int J Mol Sci. 2023 Jul 25;24(15):11912. doi: 10.3390/ijms241511912.
4
Long noncoding RNA LOC646029 functions as a ceRNA to suppress ovarian cancer progression through the miR-627-3p/SPRED1 axis.长链非编码RNA LOC646029作为竞争性内源RNA,通过miR-627-3p/SPRED1轴抑制卵巢癌进展。
Front Med. 2023 Oct;17(5):924-938. doi: 10.1007/s11684-023-1004-z. Epub 2023 Jul 12.
5
lncRNA GAS5 suppression of the malignant phenotype of ovarian cancer via the miR-23a-WT1 axis.长链非编码RNA GAS5通过miR-23a-WT1轴抑制卵巢癌的恶性表型。
Ann Transl Med. 2023 Jan 31;11(2):119. doi: 10.21037/atm-22-6394.
6
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
7
In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines.在癌症细胞系中通过反向转录定量 PCR 验证进行缺氧特征的计算机识别。
Iran Biomed J. 2023 Jan 1;27(1):23-33. doi: 10.52547/ibj.3803.
8
lncRNA TRPM2-AS Promotes Colorectal Cancer Progression by Regulating miR-22-3p and FSTL1.长链非编码RNA TRPM2-AS通过调控miR-22-3p和FSTL1促进结直肠癌进展。
J Oncol. 2022 Oct 11;2022:1366511. doi: 10.1155/2022/1366511. eCollection 2022.
9
LncRNA KCNQ1OT1 promotes the metastasis of ovarian cancer by increasing the methylation of EIF2B5 promoter.长链非编码 RNA KCNQ1OT1 通过增加 EIF2B5 启动子的甲基化促进卵巢癌细胞的转移。
Mol Med. 2022 Sep 13;28(1):112. doi: 10.1186/s10020-022-00521-5.
10
MiR-135b improves proliferation and regulates chemotherapy resistance in ovarian cancer.miR-135b 可促进卵巢癌细胞增殖并调节化疗耐药性
J Mol Histol. 2022 Aug;53(4):699-712. doi: 10.1007/s10735-022-10080-y. Epub 2022 Jul 6.